Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: PACB stock price vs BIDU: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BIDU's multiple
Needs BIDU P/S.
Implied fair value · at PACB's multiple
Needs PACB P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PACB FY 2025 (ended Dec 31, 2025) · BIDU FY 2025 (ended Dec 31, 2025).
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Pacific Biosciences of California, Inc. · implied price per share
Bear
-$2.76
Base
-$3.25
Bull
-$3.73
Baidu, Inc. · implied price per share
Bear
$6.90K
Base
$8.12K
Bull
$9.33K
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
167.73x
0.18x
Net debt / EBITDA
Leverage against operating earnings
-4.53x
-2.65x
Cash and equivalents
Liquid reserves on the balance sheet
$279.51M
$16.48B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ILLUMINA, INC.
PACB vs ILMN
THERMO FISHER SCIENTIFIC INC.
PACB vs TMO
AGILENT TECHNOLOGIES, INC.
PACB vs A
DANAHER CORP /DE/
PACB vs DHR
REVVITY, INC.
PACB vs RVTY
MICROSOFT CORP
PACB vs MSFT
Alphabet Inc.
PACB vs GOOGL
Meta Platforms, Inc.
PACB vs META
ADOBE INC.
PACB vs ADBE
Salesforce, Inc.
PACB vs CRM
$897.17M
$7.00B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
